ST Personhappiness (600079.SH): HW211026 ointment enters phase II clinical trial research.

Wisdom Financial News APP News, ST Renfu (600079.SH) announced that its wholly-owned subsidiary Hubei Biomedical Industry Technology Research Institute Co., Ltd. (referred to as "Research Institute Co., Ltd.") recently disclosed the registration information for the Phase II clinical trial of HW211026 ointment on the National Medical Products Administration's Drug Clinical Trial Registration and Information Disclosure Platform. Trial name: A multicenter, open-label, dose regimen exploration Phase II clinical study to evaluate the effectiveness and safety of HW211026 ointment in the treatment of actinic keratosis; Trial purpose: to evaluate the effectiveness of HW211026 ointment in the treatment of actinic keratosis.